spacer
home > pmps > spring 2018 > digital double-win
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital Double-Win

Today’s pharmaceutical executives navigate extremely complex territory on a daily basis. The toughest quandary they face is existential in nature: how to survive and thrive in the digital economy. Digital developments present both risks – including those connected with business, security, and compliance – and tremendous upside performance transformation opportunities.

Industry headlines are forcing executives to think long and hard about their digital transformation strategies. Consider these sample, thought-provoking headlines:

• Why did CVS buy Aetna for $69 billion? (1)
• Mylan and Teva stocks rise on report about Amazon’s pharmacy aims (2)
• Hearing Amazon’s footsteps, the healthcare industry shudders (3)
• Big Pharma builds blockchain prototype to stop counterfeits (4)
• FDA pushes DSCSA serialisation enforcement deadline to 2018 (5)
• Pharma’s digital supply chain transformation (6)

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Evren Ozkaya PhD is the Founder and CEO of Supply Chain Wizard: a full-service global consulting firm specialising in serialisation and traceability as well as supply chain strategy and operational transformation programmes. Supply Chain Wizard offers products and services targeting serialisation and supply chain transformation initiatives, along with a team of consultants providing comprehensive support towards cost-effective compliance with serialisation mandates and post-go-live operational support. Email:
spacer
Dr Evren Ozkaya
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

Philadelphia, PA & Auburn, AL – September 17, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce its exclusive collaboration agreement with CSP Technologies, Inc. for U.S. clinical trials and stability testing utilizing Activ-BlisterTM packaging solutions, which help protect and promote speed-to-market for pharmaceutical and medical device products with heightened susceptibility to moisture and gases, especially oxygen.
More info >>

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>

 
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement